盈利拐点+BD大单 信达生物无忧了?

Ofweek光电信息网
Nov 05, 2025

越是形势大好,越要居安思危!作者:张浩编辑:马可风品:李莉来源:铑财——铑财研究院冬天总会过去。经历一波深调后,中国创新药市场迎来又一爆发期。截至2025年10月份,中国创新药BD交易总额已破1000亿美元,港股已完成12宗生物科技公司IPO,合计融资13亿美元。再融资交易活跃度同频,年初至今总额已达41亿美元。撩人热度背后,除了政策市场利好,更反映了本土创新药企的强势崛起,研发实力正受到国际广泛...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10